Helmut Wolfgang Jeggle
Director at Bambusa Therapeutics; Director at BioNTech SE. Based in Boston, Massachusetts.
- Rank
- 1139th of 14,452
- Companies held
- 1
- Largest holding
- BBTX, 100.0% of total
- Latest SEC filing
- Nov 2, 2026
- Listed but not counted
- $80.5M
What the $144M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bambusa Therapeutics BBTX Common Stock | Through Salvia Investment GmbH | 9,264,301 | $15.55 | $144M | 100.0% | Form 4, Nov 2, 2026 |
Share counts are the amounts Helmut Wolfgang Jeggle reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Helmut Wolfgang Jeggle's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BioNTech SE BNTX Ordinary Shares | Indirectly (see filing footnote) Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 656,951 | $81.38 | $53.5M | — | Form 3, Mar 18, 2026 |
| BioNTech SE BNTX Ordinary Shares | Directly Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 332,316 | $81.38 | $27.0M | — | Form 3, Mar 18, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1136 | Scott J. Branch Insider, StoneX Group. New York, NY | $145M |
| 1137 | Celia Wiley 10% owner, John Wiley & Sons. Sacramento, CA | $144M |
| 1138 | Jesse C. Wiley Director, John Wiley & Sons. Sacramento, CA | $144M |
| 1139 | Helmut Wolfgang Jeggle Director, Bambusa Therapeutics. Boston, MA | $144M |
| 1140 | Sandesh Kaveripatnam Director, Navan. Palo Alto, CA | $144M |
| 1141 | Anthony F. Markel Director, Markel Group. Glen Allen, VA | $144M |
| 1142 | Rene A. Lacerte CEO, BILL Holdings. San Jose, CA | $143M |
Other Bambusa Therapeutics insiders
All BBTX insiders- Shanshan Xu$131MSee remarks. #1230 overall
Questions
How much stock does Helmut Wolfgang Jeggle own?
Helmut Wolfgang Jeggle holds $144,059,881 in listed stock based on SEC filings and current prices, mostly Bambusa Therapeutics (BBTX). That ranks 1139th on the Stock Rich List.
Is this Helmut Wolfgang Jeggle's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Helmut Wolfgang Jeggle last buy or sell stock?
The most recent open-market trade on file is a purchase of 375,000 BBTX shares on Nov 2, 2026 at $16.00.